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Abstract 
We live in a busy world, where the demand of ready-to-eat (RTE) salad products has 
increased rapidly in a relatively short time. Despite of being an easy and fast way to add more 
vegetables to the daily diet, RTE salads have a serious underlying risk and the amount of 
vegetable-derived foodborne disease outbreaks has been increasing. The aim of the present 
study is to protect plants against contamination with human pathogens by inoculating 
spinach (Spinacia oleracea) seeds with antagonists, inherent on leafy green vegetables. 
Experiments were carried on to observe the effects of selected antagonistic bacteria against 
non-pathogenic Escherichia coli CCUG29300T contamination on live spinach sprouts, and to 
test the safety by studying the immune response in mice. In addition, bacterial isolates from 
RTE rocket salad (Eruca sativa) were identified by 16S rRNA gene sequencing. The putative 
results show that bagged rocket salad contains bacteria from several different families and 
genera, the most abundant being Pseudomonas, commonly found from leafy green vegetables 
and Aeromonas that are omnipresent in soil, water and vegetation. Surprising findings were 
Rheinheimera, Chryseobacterium, and Shewanella that are more commonly associated with a 
marine environment. Unfortunately, the antagonistic effect of selected bacteria could not be 
seen in this study, as no statistically significant differences between treated samples and 
negative control were found (p>0.05). The seed pellet may work as a physical barrier 
hindering the inoculation, or has antimicrobial effects that increases the death rate of two 
antagonists. FACS analysis of Peyer’s patches and mesenteric lymph nodes of mice indicate 
that the tested antagonists may be able to suppress non-pathogenic E. coli induced 
inflammation in mice. In Peyer’s patches, the percentage of gated CCR9+CD8+CD69+ cells 
was significantly lower in the groups A (15.9 (6.2–23.2), p=0.037) and E (17.1 (7.7–25.3), 
p=0.029) compared with the control group K (30.3 (20.8–72.1)). These percentages were on 
the similar level with the untreated group N (13.7 (10.3–17.6)). The percentage of 
TLR2+TLR4+ activated macrophages in the antagonist groups varied between E 22.7 (21.7–
35.7) and B 28.9 (18.6–39.1). All results were significantly lower compared with the group K 
62.7 (57.2 – 67.9). There were no significant differences in water or feed intakes between 
groups, which indicates that antagonist treatment do not make mice feel sick. This study 
supports the current knowledge of leafy green vegetables harbouring a very diverse 
microflora with genera with potential human pathogens. Despite of poor results in 
antagonistic effect experiment, preliminary results indicate that selected antagonists do not 
trigger a negative immune response in mice. 
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1 Introduction 
Consuming vegetables, berries and fruits have numerous health-promoting effects. Leafy 
green vegetables, including spinach, are found to be a good source of minerals, ascorbic acid 
(vitamin C), and iron (Singh, Kawatra and Sehgal, 2001). In addition, vegetables, fruits and 
berries have a high amount of dietary fibre (Campos, Mourão, Pestana, Peixe, Novais and 
Antunes, 2013) that supports the gastrointestinal functions (Schneeman, 1998). The 
consumer awareness and demand have expanded the market for ready-to-eat (RTE) salads 
and salad mixes that can be bought around the year (Campos et al., 2013). RTE salads seem 
to be a great way to increase the vegetable consumption, but despite of the positive health 
promoting effects they also have an underlying safety issue that some consumers may not be 
aware of (Campos et al., 2013).  
An increasing amount of vegetable-derived foodborne disease outbreaks have been recorded 
during last few years. A long-term American study with pre-electronically and electronically 
collected data from 1973 to 2012 revealed, that the annual amount of leafy green derived 
outbreaks have increased from a median of 4 to a median of 37, but the amount of patients 
per outbreak has decreased from a median of 39 to a median of 14 (Herman, Hall and Gould, 
2015). The most common pathogen was norovirus, and it was followed by shiga toxin 
producing Escherichia coli (STEC), and Salmonella (Herman et al., 2015). However, a similar 
trend has also been seen in Europe where several links between foodborne disease outbreaks 
and leafy greens like spinach, lettuces and RTE mixes have been reported (Mercanoglu Taban 
and Halkman, 2011). For example, nearly 200 people in Finland got sick from STEC 
serogroup O157 contaminated RTE salad in summer 2016 (Yle News, 2016). 
The present study is a prolongation of an advanced course project (KLG410, 15 ECTS), that 
was carried out by the same author in Lund University from September to December 2016. 
The aim of the project was mainly to investigate the effects of household storage on the total 
microbial load and the survivability of inoculated, non-pathogenic Escherichia coli 
CCUG29300T (Culture Collection of Göteborg, T implies typestrain) in RTE rocket salad 
bags over the shelf-life of nine days. Results showed that the total aerobic bacterial load of 
untreated bags increased from 7.1 log10 CFU/g to log 8.7 log10 CFU/g and total 
Enterobacteriaceae concentration increased from 3.4 log10 CFU/g to 4.0 log10 CFU/g. The 
development of total aerobic bacteria count was concordant with bags with E. coli 
CCUG29300T. Even though the concentration of inoculated E. coli CCUG29300T decreased 
from 5.4 log10 CFU/g to 4.3 log10 CFU/g, there is a strong indication that E. coli can survive 
in household storage conditions. In the future the same experiment will be tested with E. coli 
strain inherent on salads. 
During this study, few bacterial isolates from the mentioned advanced course project were 
identified to be able to characterize the microbial flora of RTE rocket salad mix over the 
self-life period. The aim of this study is to protect plants against contamination with human 
pathogens by inoculating seeds with antagonists inherent on leafy green vegetables. This 
could be an efficient way to decrease the leafy green derived outbreaks in the future. The 
survivability and antagonistic activity of the five potential candidates were tested with spinach 
seed and sprout experiments. An animal study was also performed to test the safety of the 
antagonists by studying the immune response in mice upon consumption. 
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2 Literature study 
2.1 Microbial quality and safety of leafy green vegetables 
Leafy green vegetables, usually spinach, lettuces and their RTE salad mixes are potential 
carriers of human pathogens. King, Magnuson, Török and Goodman (1991) ran an 
experiment to characterize the microflora of partially processed lettuce (Latuca sativa). They 
found several bacteria for example from the genera Enterobacter, Erwinia, Pseudomonas and 
Bacillus, which are known to have members with human pathogenic potential. When some 
of these bacteria are inherit on the leafy green vegetables, it is important to realize that the 
contamination with potential pathogens can happen in every stage from pre-harvest to the 
kitchen of a consumer (Mercanoglu Taban and Halkman, 2011). Potential pathogens at the 
pre-harvest stage are Escherichia coli, Salmonella spp., Listeria, as well as different parasites and 
viruses (Mercanoglu Taban and Halkman, 2011). Contamination can naturally happen 
through the soil or irrigation water. However, since the postharvest stage includes everything 
from transporting and processing to retail, there are several points of potential contamination. 
The hazard potential is high, because RTE salads do not undergo any processing steps to 
eliminate the contaminants. In addition, when salad leaves get damaged during handling or 
transportation, the leaking juice works as a strong growth enhancer for bacteria (Koukkidis, 
Haigh, Allcock, Jordan and Freestone, 2016). Therefore, maintaining the microbial safety of 
leafy green vegetables and their RTE products is essential on every processing step, and 
requires commitment from every operative throughout the food chain (Mercanoglu Taban 
and Halkman, 2011). 
2.2 Immune system – The defender of the body 
The mammalian body is a highly developed system with several structures and processes. 
This system would be extremely sensitive against pathogens without a layered defence system. 
The body has several ways to protect itself from potentially harmful microbes and substances, 
as well as to remove them. The immune system is a group of cells, molecules and tissues that 
are preventing infections and exterminating the ongoing ones (Abbas, Lichtman and Pillai, 
2015). This system is capable to react to the pathogens in various ways, and these reactions 
are called the immune response (Abbas et al. 2015). 
The first line of our natural immune system, also known as the innate immune system, is the 
epithelial barriers such as skin and mucosa (Janeway, Murphy, Travers, Walport and 
Ehrenstein, 2008). If these layers get damaged and the infectious microbe gets in contact 
with other organs, the damaged area gets swollen, red and hot. This reaction, inflammation, 
is the first immune response of our immune system after it receives stress signals from the 
damaged or infected cells. Several infections are successfully eradicated by the innate immune 
system and do not lead to diseases (Abbas et al., 2015). However, if the innate immune system 
encounters a resistant pathogen and fails to eliminate it, signals to activate the adaptive 
immune system are sent (Abbas et al., 2015). Elimination of harmful microbes by the adaptive 
system is followed by immunological memory (Janeway et al., 2008). 
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2.2.1 Factors of the immune system 
An essential part of our immune system is the lymphatic system, a highly specialized entirety 
of vessels (Janeway et al., 2008). Circulating fluid in the lymphatic system, lymph, is formed 
when interstitial fluid from tissues is collected by lymph capillaries (Choi, Lee and Hong, 
2012). Collected lymph is cleaned in the lymph nodes, an enclosed capsule of several 
lymphoid lobules and sinuses, and the cleaned lymph gets migrated back with the blood 
(Choi et al., 2012). During this circulation process, antigens are transferred to the lymph 
nodes and lymphocytes back to the blood (Janeway et al., 2008). Mice have 22 known lymph 
nodes, while humans have approximately 20 times more, and these organs play an important 
role in the interaction between antigen presenting cells (APC) and lymphocytes (Willard-
Mack, 2006). In the gut, the sorting between pathogens and commensal microflora is 
managed by the interaction between epithelium and the gut-associated lymphoid tissue 
(GALT) (Jung, Hugot and Barreau, 2010). The most important part of GALT are Peyer’s 
patches which are highly organized structures that get their antigens via multi-fenestrated 
epithelial cells, M cells (Janeway et al., 2008). 
Innate and adaptive immunity depend on the actions of white blood cells, leukocytes. Like 
every other cellular element of blood, leukocytes are derived from the hematopoietic stem 
cells in the bone marrow and the cell subsets are formed after different maturation pathways 
(Janeway et al., 2008). To be able to recognize pathogens and respond to their presence, 
leukocytes express different receptors (Janeway et al., 2008). These receptors are proteins that 
are specialized to recognize different molecules produced by both non-infectious and 
pathogenic molecules, and activate a chain of reactions based on the encounter (Abbas et al., 
2015). 
Macrophages are important cells of the innate immune system, and are able to start the 
inflammatory response. When a macrophage encounters a pathogenic bacteria, it starts to 
release chemokines and cytokines to increase the permeability of blood vessels and to guide 
neutrophils to the infected area (Janeway et al., 2008). Macrophages are casually called as big 
eaters, because they also devour the harmful bacteria in the process called phagocytosis 
(Janeway et al., 2008). Macrophages express marker F4/80, and the high amount of them 
usually indicates that the body contains numerous harmful bacteria (Janeway et al., 2008). 
Furthermore, together with microphages, macrophages can also express Toll-like receptor 
(TLR) 4 or 2 based on what type of pathogen they have devoured (Janeway et al., 2008). 
TLR2 is associated with Gram-positive bacteria, and TLR4 with Gram-negative bacteria 
(Janeway et al., 2008). Gram-negative bacteria include human pathogens like Escherichia coli, 
Yersinia, and Pseudomonas aeruginosa. 
Dendritic cells (DCs) work in both the innate and the adaptive immune system, expressing 
the CD11c marker. New DCs migrate from the blood to the peripheral tissues, where they 
keep ingesting the surrounding extracellular fluids (Janeway et al., 2008). When a DC 
encounters a pathogen, it undergoes a quick maturation and migrates to the lymph nodes 
where it works as an antigen presenting cell for T cells, triggering the adaptive immune 
response (Janeway et al., 2008). 
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The naive lymphocytes need two signals to get activated (Janeway et al., 2008). The first signal 
appears when an antigen binds to the cell receptor, and the second signal is given by APC 
with antigens presented on its major histocompatibility complex (MCII) peptide (Janeway et 
al., 2008). 
On T cells, the activation can cause proliferation through two major pathways into effector 
cells: Helper T cells (effector CD4+), which secrete cytokines to attract macrophages, 
neutrophils and other co-operators towards the harmful cells, and cytotoxic T cells (CD8+), 
which are directly attacking cells that are expressing intracellular antigens (Abbas et al., 2015). 
T regulatory (Treg) cells also belong to the subset of T cells and have an important function 
on suppressing and downregulating the accumulation of effector CD4+ cells and therefore, 
preventing autoimmune diseases (Bettelli et al., 2006). Treg cells express not only the markers 
CD69 and FOXP3, but also CD25 and CD4, which makes differencing between CD4+ cells 
and Treg cells sometimes challenging (Bettelli et al., 2006). CC chemokine receptor 9 (CCR9) 
expressing T cells are homing and activating specifically in the lamina propria mucosæ and 
epithelium of small intestine, and can then be used to investigate the infections of the gut 
(Wurbel, Malissen, Guy-Grand, Meffre, Nussenzweig, Richelme, Carrier, and Malissen, 
2001). B cells have different activation ways, and the most significant is receiving the signal 
from an activated (follicular) T helper cell (Janeway et al., 2008). Activated B cells do not 
attack on other cells, but instead proliferate into plasma cells and start producing antibodies 
- special proteins that are designed to work against antigens by triggering mechanisms that 
eliminate or block them (Abbas et al., 2015). A generic structure of an antibody is presented 
in Figure 1. 
 
Figure 1 - A generic structure of an antibody 
Specific antibodies can be used as biomarkers, quantifiable distinctive mark of biological 
processes when study has a well-defined clinical endpoint (Strimbu and Tavel, 2010). 
2.3 Fluorescence-activated cell sorting (FACS) 
By knowing the expressing markers of different intra- or extracellular proteins, the presence 
of the corresponding immune cell can be investigated with fluorescence-activated cell sorting 
(FACS). The fluorescence conjugated antibodies react specifically to the wanted proteins, 
which provides an efficient method to sort cells based on the specific light scattering 
(Graham, 2006). The cell suspension gets entrained by a rapid liquid stream as single cell 
flow, from which the cells are separated by a set of filters and mirrors, and finally registered 
Heavy chain 
Light chain 
Antigen 
Variable area 
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by the generated signal (Graham, 2006). This allows precise cell count on wanted cell 
populations, selected by gating the known characteristics, expressing marker, side scatter, 
and forward scatter (Graham, 2006). Scatter data is specifically used to outline the signals 
from clumped cells and impurities (Graham, 2006). Since the data analysis is dependent of 
the correct gating, it is required to run a compensation with either beads or single stained 
cells to prevent double positive signals (Graham, 2006). 
2.4 Growth media used 
Growth media was used to cultivate frozen antagonists, and bacteria from the spinach 
sprouts. All materials were autoclaved or prepared with given instructions, and stored in a 
refrigeration room at 8 °C when not in use. Tryptic Soy Broth, TSB (Sigma-Aldrich, 
Hamburg, Germany), is a multipurpose growth promoting liquid used to cultivate E. coli and 
the antagonists A–C. Tryptic Soy Agar, TSA (Sigma-Aldrich, Hamburg, Germany), is a 
multipurpose medium, which is used in solid form to support the growth of several non- or 
slightly fastidious microbes. Prepared TSA plates were used to investigate and monitor the 
aerobic bacterial load of spinach sprouts. De Man, Rogosa and Sharpe, generally abbreviated 
to MRS, broth and agar (Merck KGaA, Darmstad, Germany) are non-selective media used 
to abundant growth of lactic acid bacteria. MRS broth and agar was used to cultivate 
antagonists D and E. The presence and concentration of E. coli were investigated by using 
Brilliance E. coli/coliform Selective Agar, ECBA (Oxoid, Hampshire, England). ECBA 
contains two chromogenic agents Rose-Gal and X-Glu, which are used to detect ß-
galactosidase and ß-glucuronidase activity, giving E. coli colonies a dark purple colour. Media 
also contains sodium layrul sulphate to inhibit the growth of Gram-positive microbes (Oxoid, 
n.d.). 
3 Materials and methods 
3.1 Identification of the bacterial isolates from bagged rocket salad 
Bacterial isolates from RTE rocket salad (Eruca sativa) bags were collected by randomized 
sampling over the period from November 22 to December 3, 2016. Frozen bacteria isolates 
were thawed and transferred on TSA plates with sterile 1 µl loops. Plates were incubated in 
30 °C or 37 °C based on which growth media they originated from, and checked after 24–
48 hours depending on the colony growth speed. Plates that contained only one type of 
colony (see Figure 2) were considered to be pure, and a single colony was transferred to a 
1.5 ml safe-lock microcentrifuge tubes (Eppendorf, Hamburg, Germany) with 8–10 small 
sterile glass beads and 0.5 ml of ultrapure (Milli-Q) water. Tubes were then shaken with an 
Eppendorf Mixer 5432 (Eppendorf, Hamburg, Germany) for 30 minutes and stored at -
20 °C. 
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Figure 2 - Purified bacteria isolates from ready-to-eat rocket salad bags. 
3.1.1 Polymerase chain reaction (PCR) and gel electrophoresis 
Thawed samples were centrifuged (8 rpm for 1 min) and the DNA extract (supernatant) 
collected. The random 16S rRNA genes were amplified using forward primer ENV1 (5’-
AGA GTT TGA TII TGG CTC AG-3’) and reverse primer ENV2 (5’-CGG ITA CCT TGT 
TAC GAC TT-3’) from Eurofins Genomics, Germany. 2.5 µl of sample DNA was mixed 
with 22.5 µl of the PCR Master Mix that contained 18.375 µl of nucleus free water (Qiagen, 
Germany), 2.5 µl of TopTaq 10 x PCR buffer (Tris-HCl, KCl, (NH4)2SO4, 15 mM MgCl2, 
pH 8.7) (Qiagen, Germany), 0.5 µl of deoxynucleotide (dNTP) solution mix (Qiagen, 
Germany), 0.5 µl of each primer, and 0.125 µl of TopTaq DNA Polymerase (Qiagen, 
Germany). The negative control sample was prepared in the same way, but 2.5 µl of nucleus 
free water was used instead of sample DNA. The PCR was performed in Eppendorf 
Mastercycler gradient (Eppendorf, Hamburg, Germany) using TopTaq25 program with the 
following steps: Initial denaturation at 94 °C for 3 min, 25 cycles of denaturation at 94 °C 
for 30 s, annealing at 60 °C for 30 s, and extension at 72 °C, for 1 min. In the end, the final 
extension at 72 °C for 10 minutes was done (Qiagen, 2010). 
The quality and yield of amplified PCR products were tested by 1.5% Agarose Gel 
Electrophoresis, 60 minutes at 120 V in Bio-Rad Power Pac 300 (Bio-Rad, USA). To visualise 
the amplification product (see Figure 3) gel was stained with 0.03% GelRed™ Nucleic Acid 
Gel Stain 10000x (Biotium, USA) for 20 minutes and observed on UV transilluminator (UVP, 
USA). Samples with good yield and quality were sent to Eurofins Genomics, Ebersberg, 
Germany for sequencing on an ABI 3130xl Genetic analyser (Applied Biosystems, Foster 
City, CA, USA) with ENV1 as sequencing primer. 
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Figure 3 - Dyed PCR amplification products of isolates from ready-to-eat salad bags on 1.5% agarose gel after gel 
electrophoresis. Gel does not contain ladder. 
3.2 Effects of the selected antagonist on spinach sprouts 
To investigate antagonistic effects of the selected bacteria on spinach sprouts (Spinacia 
oleracea), pelleted seeds were supplied from Södervidinge gård, Kävlinge, Sweden. Selected 
antagonists from previous experiment are from different bacterial orders, but all of them 
have shown potential antagonistic activity against Escherichia coli in vitro. In this paper, the 
selected antagonists are called A, B, C, D and E. The isolates were stored in a freezer at -
81 °C and thawed only for inoculation purposes. Before seed inoculation, frozen isolates 
were incubated using growth media, temperatures and times shown in Table 1. 
Table 1 - Used growth media, incubation temperatures and incubation times for selected antagonists 
Antagonist Growth medium Incubation temperature Incubation time 
A and B TSB 30 °C 24 hours 
C TSB 30 °C Three days 
D and E MRS 37 °C Three days 
 
Incubated tubes were centrifuged (6000 rpm for 5 minutes) and the supernatant discarded. 
To wash the culture, 8 ml of nutrient solution (for composition, see Appendix 1) was added, 
tubes centrifuged again, remaining supernatant discarded, and finally 6 ml of nutrient 
solution was added. The required amount of cells per 1 ml of solution was 108. To check the 
concentration, the optical density (OD) of the culture was measured at wavelength of 620 
nm in a spectrophotometer (Pharmacia Novaspec II). The required OD values are shown in 
Table 2. 
Table 2 - Required OD8 (620 nm) values for used antagonists 
Antagonist A B C D E 
OD8620nm 
+/- 0.002 
0.016 0.020 0.236 0.265 0.211 
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The first set seeds were placed on rockwool plugs (IKEA, Sweden), three seeds per plug. 
Seeded plugs were placed in sterile glass jars, three plugs per jar, with 20 ml of nutrient 
solution. To start sprouting in dark, jars were placed in a sealed cardboard box and left for 
one week at room temperature. After one week, bottles were placed under UV-LED lights 
for five days to promote growth of sprouts. A timer was used to simulate the day and night 
cycle with 6.5 hours of darkness and 17.5 hours of light. After five days, an antagonist 
solution with the concentration of 108 colony forming units per millilitre (CFU/ml) was 
prepared and sprouts were dipped in for 10 seconds. The time was based on the previous 
studies. Growth under UV-LED lights was continued for 5 days before dipping in E. coli 
CCUG29300T solution with the same concentration and dipping time. Growth under UV-
LED lights was continued for two days.  
For sets two and three instead of dipping the sprouts, the seeds were inoculated with the 
wanted antagonist. A set (n=6) of 8 to 10 seeds were transferred in 1.5 ml microcentrifuge 
tubes with 1.0 ml of solution, and incubated in room temperature for 5 hours. The seeds for 
negative control were prepared in the same way, but microcentrifuge tubes contained only 
1.0 ml of nutrient solution. The growing procedure was the same as previously, but E. coli 
dip was done right after the first 7+5 days. 
After the growing period, healthy sprouts (Figure 4) were cut off and weighed. Roots and 
dead or rotten sprouts were discarded (Figure 4). Weighed sprouts were put in a mortar, and 
crushed well with added 2.0 ml of peptone water (8.5 g/l of sodium chloride (Merck, 
Darmstadt, Germany) and 1 g/l of bacteriological peptone (Oxoid, Hampshire, England)) 
to create a nearly homogenous solution. The serial dilution was made from 100 to 10-5 and 
the spreading was done on ECBA from 100 to 10-3, and on TSA from 10-2 to 10-5. TSA plates 
were incubated at 30 °C for three days, and ECBA plates at 37 °C for 24 hours. Colony count 
was performed to all plates after the incubation. 
 
Figure 4 - Examples of healthy sprouts (left) and discarded material (right). 
  
 9 
 
3.2.1 Survivability of the antagonists on pelleted seeds 
Nutrient solution with 108 CFU/ml of the antagonistic bacteria was spread on TSA or MRS 
plates, depending on the used bacteria. This was done to get a comparable sample. To 
investigate if the pelleting material on spinach seeds is toxic for the used antagonist, 20 seeds 
per antagonist (ntot=100) were sprayed with ethanol to disinfect the surface, let to dry in a 
laminar flow hood, and transferred to Falcon tubes with 2.0 ml of nutrient solution with 108 
CFU/ml of the antagonist. Seeds were kept in the solution for 5 hours, after which the 
solution was spread on TSA or MRS plates. TSA plates were incubated at 30 °C, and MRS 
plates at 37 °C for 1–3 days before the colony count. 
3.3 Animal experiment to investigate the safety of selected antagonists 
Wild type (WT) black female C57BL/6 mice (Charles Rivers Laboratories International Inc. 
Germany) with body weight 18.6–22.0 g, were kept in standard conditions in the animal 
faculty of Lund University with seven days to get used to the surroundings before starting 
the experiment. Animals had free access to standard feed and specially prepared water. All 
experiments followed the relevant Swedish and Institutional laws and guidelines (Ethical 
permit 6202/2017, Malmö - Lunds djurförsöketiska nämnd). 
3.3.1 Treatment period 
70 mice were randomly sorted in 7 groups (nGT=10) and each group was divided in two cages 
as duplicate groups (nG=5). The groups were normal N1 and N2, control K1 and K2, and 
antagonists A1, A2…E1, E2. To identify each individual, the white fur patches behind the 
mice’s ears were dyed with non-toxic animal markers. All the groups except N1 and N2 were 
given antibiotics and Escherichia coli CCUG29300T as pre-treatment to equalize the gut 
microbiota and reduce the amount of Lactobacillaceae. The water consumption was determined 
and new water (100 ml) prepared every day. An average dose of 5.2 (3.7–6.4)* mg of 
metronidazole, 3.5 (2.5–4.3)* mg of amoxicillin, and 2.1 (1.5–2.5)* mg of clindamycin was 
consumed per each mouse for three days. During the antibiotic treatment period each group, 
N groups included, had their water supplemented with 2% (w/v) fructose. An average daily 
dose of E. coli per animal was 108 CFU for two days right after antibiotics. After the pre-
treatment, groups A1–E2 were given water supplemented with corresponding antagonist A–
E with an average daily dose of an antagonist being 108 CFU per animal. Because antagonists 
were frozen with 0.5 ml of Hogness freezing media (for composition, see Appendix 2), water 
for the groups N and K were supplemented with the corresponding dose. A detailed 
experiment schedule and supplements are presented in Appendix 3. 
(*)Presented amounts are median mg/day per mouse with 25th and 75th percentile. 
3.3.2 Operation 
On treatment day 21, the animals (n=10) were put under anaesthesia by Domitor® 
(medetomidine 1 mg/ml) + Ketalar® (ketamine 50 mg/ml) injection with 1.0 mg/kg of 
medetomidine and 75 mg/kg of ketamine per dose. Two animals were always kept together 
to reduce the stress after handling. Arterial blood was collected for later analysis of cytokines. 
A laparotomy was done through a midline incision to collect mesenteric lymph nodes, liver, 
spleen and the whole gastrointestinal tract from duodenum to the anal verge. Animals were 
euthanized with pentobarbital injection. Peyer’s patches were collected from the whole small 
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intestine for FACS analysis together with the mesenteric lymph nodes. Intestinal biopsies for 
myeloperoxidase (MPO) activity and microbial evaluation were collected from both the small 
and large intestine, as well as faecal samples. Scheme for intestinal sampling is presented in 
Figure 5. 
 
Figure 5 - Schematic picture of intestinal sampling. For faecal samples, all intestinal content were collected from the 
cross-hatched sections. 
All but lymphatic tissue samples were weighed and quickly frozen with dry ice, excluding the 
spleen that was discarded after weighing. Biopsies for MPO analysis were frozen in Tris-
EDTA-buffer. Peyer’s patches and mesenteric lymph nodes were transferred in Falcon tubes 
(Corning Science Mexico S.A. de C.V., Mexico) with Hank’s Balanced Salt Solution (HBSS) 
with phenolic red pH-indicator (Biowest, Nuaillé, France) and the tubes were kept in wet ice 
until the preparation for FACS.  
3.3.3 FACS 
Peyer’s patches and mesenteric lymph nodes were transferred from Falcon tubes to 1.5 ml 
microcentrifuge tubes with 1 ml of HBSS, cut into small pieces, and centrifuged (100 x g) at 
4 °C for 2 minutes. The supernatant with fat was removed, and the remaining tissue was 
transferred into a FACS tube (BD Biosciences, Durham, USA) and digested with digestion 
mix (collagenase P, dispase II protease, DNase I and HBSS) in a rocker at 37 °C for 10 
minutes. To hasten tissue breakdown, the mixture was pipetted up and down before letting 
the sample to set. Supernatant with cells was transferred to a tube with 5 ml of HBSS and 
10 % foetal bovine serum (FBS) (VWR, Radnor, USA) placed on ice. After 1–3 repeats the 
remaining cell suspension was centrifuged (1400 rpm) at 4 °C for 5 minutes, the supernatant 
removed and cells resuspended in 2 ml of HBSS/10% FBS. The new suspension was 
transferred through a 40 μm cell strainer (VWR, Radnor, USA) to a FACS tube, and the 
strainer was washed with 1 ml HBSS/10% FBS. The suspension was centrifuged (1400 rpm) 
at 4 °C for 5 minutes, supernatant discarded and cells resuspended in 500 μl of HBSS. For 
correct gating, one set of cells were stained with Türk’s solution (Merck KGaA, Darmstad, 
Colon 
Small intestine 
Caecum 
Stomach 
Rectum 
Biopsy for 
MPO 
Biopsy for 
MPO 
Biopsy for 
microflora 
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Germany), counted, and the needed volume of HBSS to dilute the suspension to 106 cells 
was calculated. 
Unstained cells were stained in an antibody solution for 15 minutes at 4 °C in dark for the 
following biomarkers from eBiosciences Inc, San Diego, USA: CD4, CD8a, CD11c, CD25, 
CD69, CCR9, F4/80, TLR2 and TLR4. Stained cells were then washed with 800 μl FACS 
buffer and resuspended in 400 μl of FACS buffer. For intracellular (Foxp3 (eBioscience Inc, 
San Diego, USA)) markers, cells were permeabilized and fixed according to the protocol, and 
resuspended in 400 µl FACS buffer. The following antibody panels were used: 
Panel 1: TLR2, TLR4, CD11c, F4/80 
Panel 2: CCR9, CD4, CD69, CD8a 
Panel 3: CD4, Foxp3, CD69, CD25 
In every panel, the unwanted cells were blocked by unstained CD16/CD32 antibody. Stained 
cells were stored overnight at 4 °C until FACS analysis. FACS analysis was performed at 
CRC, Malmö on a CytoFLEX (Beckman Coulter, USA). Depending on the total amount of 
cells in a sample, 10 000–50 000 events were obtained for analysis. Collected data was 
analysed with CytExpert 2.0 (Beckman Coulter, USA). For the full protocol, see Appendix 
4. 
3.4 Statistical analysis 
All data was analysed by SigmaPlot 13.0 (SPSS Inc., Chigago, USA) to see if results have a 
statistically significant difference between them. The differences between all groups were 
evaluated by one-way ANOVA on ranks (The Kruskal-Wallis on ranks). All-pairwise-
multiple-comparison was analysed either by Student-Newmans-Keuls for groups with equal 
sample sizes, or Dunn’s method if the sample size were unequal due missing samples. The 
comparison between two groups were tested by a Mann-Whitney rank sum test. Results were 
regarded to have statistically significant difference when p<0.05. All values are presented as 
median (25th percentile–75th percentile). 
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4 Results 
4.1 Identification of isolated bacteria from RTE rocket salad bags 
The results of the 16S rRNA gene sequenced isolates from ready-to-eat rocket salad bags are 
presented in Table 3. Bacteria from the Pseudomonaceae family were isolated mostly from TSA 
plates throughout the shelf-life of nine days, however one bacteria from the same family was 
isolated from VRBD plate. Most of Aeromonadaceae were isolated from VRBD plates, as well 
as one member of Moraxellaceae family. A bacteria from Chromatiaceae family was isolated from 
one of the bags in the beginning of shelf-life, while members of Flavobacteriaceae and Bacillaceae 
families were isolated from bags in the middle of the shelf-life period. Two members of 
Shewanellaceae were isolated from the samples on the last day of the shelf-life. 
Table 3 - Supposed identification of isolated colonies from ready-to-eat rocket salad bags over the shelf-life period of 
nine days. Colonies are isolated from countable plates of the total aerobic bacterial load (TSA) and 
Enterobacteriaceae plate (VRBD) and identified by 16S rRNA gene sequencing. 
Closest type strain1 Similarity (%) TSA2 VRBD3 
Isolated from bags during shelf-life days 1-3 
Acinetobacter haemolyticus M0430 96.3  1 
Aeromonas media R36 98.8 1E  
Pseudomonas baetica DSB2 99.0 1  
Pseudomonas extremorientalis KMM 3447T 100.0  1 
Pseudomonas putida AZ22R1 99.8 1  
Rheinheimera soli B29 99.1 1E  
Isolated from bags during shelf-life days 5-7 
Aeromonas hydrophilia HC010916B-1 98.8 1  
Chryseobacterium indoltheticum KUDC1754 98.6 1  
Lysinibacillus fusiformis Y11 99.8 1  
Pseudomonas fragi p423 99.8 1  
Isolated from bags on self-life day 9 
Aeromonas hydrophilia 45/90 100.0  2 
Aeromonas media 83a 99.8  1 
Aeromonas media AF63 100.0 1  
Aeromonas sp. I_6-G7221B10B 100.0  1 
Pseudomonas cedrina P515/12 99.8 1  
Shewanella putrefaciens LMG 26268T 97.4 1  
Shewanella putrefaciens Sh3 100.0 1  
1 According to RDP database, Seqmatch software 
2 Number of isolated colonies from TSA 
3 Number of isolated colonies from VRBD 
E Isolated from a batch with inoculated E. coli CCUG29300T 
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4.2 Effects of selected antagonist on spinach sprouts 
Escherichia coli concentration varied between 6.80 (6.51-6.97) log10 CFU/g and 6.90 (6.76-
7.05) log10 CFU/g on the samples that were dipped in both the antagonist and E. coli 
solutions. When pelleted seeds were inoculated with the antagonist, E. coli concentration 
varied between 6.54 (5.58-7.10) log10 CFU/g and 7.17 (6.85-7.63) log10 CFU/g on set 2, and 
between 6.57 (6.20-7.25) log10 CFU/g and 7.08 (6.74-7.46) log10 CFU/g on set 3. Possible 
difference between the antagonists was not taken into account, since the antagonists are not 
dependent on each other. Results are presented in Table 4. 
Table 4 - Bacteria concentration on spinach sprouts in the end of growing period for sets 1–3. Results are presented 
as median (25% - 75%) log10 CFU/g. ECBA represents Escherichia coli concentration, TSA represents total aerobic 
bacterial concentration. 
Set 1: Antagonist dip + E. coli dip 
Antagonist A B C D E NEG 
ECBA 
6.54 (6.38-
7.07) 
6.62 (6.44-
7.43) 
6.35 (6.08-
6.61) 
6.80 (6.51-
6.97) 
6.57 (6.28-
7.21) 
6.90 (6.76-
7.05) 
 
 
TSA 
9.24 (8.99-
9.47) 
8.90 (8.75-
9.21) 
8.85 (8.52-
9.20) * 
9.45 (9.29-
9.58) * 
9.02 (8.45-
9.23) 
9.32 (8.98-
9.37) 
Set 2: Seed inoculation + E. coli dip 
Antagonist A B C D E NEG 
ECBA 
7.17 (6.85-
7.63) 
6.59 (6.06-
7.02) 
7.09 (6.88-
7.37) 
6.67 (6.28-
6.83) 
6.54 (5.58-
7.10) 
6.77 (6.37-
7.02) 
 
 
TSA 
9.70 (9.45-
10.23) 
9.23 (8.87-
9.46) 
9.66 ( 9.19-
9.87) 
9.47 (9.14-
10.17) 
9.44 (9.00-
9.77) 
9.76 (9.12-
10.00) 
Set 3: Seed inoculation + E. coli dip 
Antagonist A B C D E NEG 
ECBA 
7.08 (6.74-
7.46) 
7.04 (6.85-
7.27) 
6.57 (6.20-
7.25) 
6.94 (6.80-
7.03) 
6.92 (6.54-
7.16) 
7.08 (6.61-
7.28) 
 
 
TSA 
9.63 (9.26-
9.80) * 
9.19 (8.88-
9.43) 
9.50 (9.26-
9.62) 
9.24 (9.13-
9.62) 
8.58 (8.39-
9.08) 
9.02 (8.90-
9.25) 
* indicates that there is a statistically significant difference (p<0.05) compared with NEG. 
No significant differences in Escherichia coli concentrations between antagonists and negative 
control were found in any experiment set. On total aerobic microbial concentration, there 
are significant differences between the antagonist C (8.85 (8.52–9.20) log10 CFU/g) and NEG 
(9.32 (8.98–9.37) log10 CFU/g), p=0.041, and between the antagonist D (9.45 (9.29–9.58) 
log10 CFU/g) and NEG (9.32 (8.98–9.37) log10 CFU/g), p=0.041 in set 1. Also in set 3, a 
significant difference between the antagonist A (9.63 (9.26–9.80) log10 CFU/g) and NEG 
(9.02 (8.90–9.25) log10 CFU/g), p=0.015 was found. 
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4.2.1 Survivability of antagonists on pelleted spinach seeds 
The results of survivability experiment is shown in Table 5. Inoculating pelleted seeds in 
antagonist solution for 5 hours decreased the concentration of the antagonist D from 5.29 
log10 CFU/ml to 3.26 log10 CFU/ml and of the antagonist E from log10 7.00 CFU/ml to 6.00 
log10 CFU/ml. The median concentration of the antagonist A increased from 7.40 log10 
CFU/ml to 7.58 log10 CFU/ml. 
Table 5 – Median of triplicate log10 CFU/ml values of antagonists A–E without seeds, and after incubating seeds in 
the solution for 5 hours. 
Antagonist A B C D E 
 Median log10 CFU/ml 
Without seeds 7.40 7.92 7.18 5.29 7.00 
With seeds 7.58 7.82 7.13 3.26 6.00 
 
4.3 Animal experiment 
There were no significant differences in feed consumption (Appendix 5, pconsumption=0.448) 
or water intake between the groups K and A–E (p=0.718). The difference between the group 
N and other was not tested due the different treatment. The graph of daily water intake of 
the different groups is presented in Figure 6. 
 
 
Figure 6 - Daily water intake. Each data point is a median of two collateral groups. Missing data point on the group C 
(day 4) and on the group E (day16). 
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The mice’s weights were registered (Appendix 6) in three time points (start, after E. coli 
treatment, and in the end) during the study. The statistical analysis showed that there is no 
significant differences (p=0.563) in overall weight changes with compensated feed intake. In 
addition, there was no significant pairwise differences in feed compensated weights between 
the control group K and the antagonist groups A–E over the antagonist treatment period 
(15 days). 
Cells from spleen were not collected, but the spleen weights were registered and 
compensated with feed intake and the end weights of mice (Appendix 7). The mouse C1.4 
had notably bigger spleen than other individuals, but no significant differences were found 
between spleen weight with or without the compensations. Observation during the surgery 
also revealed that the mouse K1.2 had notably redder mesentery compared to other 
individuals. Furthermore, several mice from the antagonist groups D and E had slimy small 
intestinal content. 
4.3.1 Immune response of mice  
Mononuclear cells were collected and prepared from mesenteric lymph nodes and Peyer’s 
patches and analysed by FACS for cell population observation. All result comparisons are 
done with the E. coli pre-treated control group K. The results of FACS analysis for mesenteric 
lymph nodes are presented in Table 6. The percentage of CD11c+TLR2+ is significantly 
lower in the groups N (4.9 (3.8–6.1)) and A (7.3 (6.2–8.1)) compared with the group K (18.7 
(18.1–20.6)) in cells gathered from mesenteric lymph nodes. Additionally, percentages in the 
antagonist groups C–E were significantly higher, C being the highest (78.8 (76.7–86.0)). 
Moreover, the percentage of CD11c+TLR4+ dendritic cells in mesenteric lymph nodes were 
significantly higher in the antagonist groups B–E compared with the group K. All significant 
differences in F4/80 macrophages from mesenteric lymph nodes were lower than the group 
K. The only exception was with F4/80+TLR4+ macrophages, where the percentage was 
slightly higher in the group A (52.5 (50.2–56.0)) compared with the group K (42.7 (39.5-
49.0)), p=0.038. A few regular patterns in the percentages of different gut homing T cells 
can be seen. The percentage of activated helper T cells (CCR9+CD4+CD69+/CD69-) and 
cytotoxic T cells (CCR9+CD8+CD69+/CD69-) are significantly higher in the untreated 
group N (p≤0.001) and the antagonist groups E and D (p≤0.001) compared with the control 
group K. The activation percentage of the same cells in the antagonist groups A–C is mostly 
significantly lower compared with the group K, except in CCR9+CD4+CD69- cells where 
the percentage is significantly higher. The percentage of CD4+CD25+Foxp3+CD69+ 
regulatory T cells is significantly higher in the group N (p≤0.001), and in the groups A–E 
(p≤0.001, except in C where p≤0.01) compared with K (10.8 (7.6–12.5)). The results of 
FACS analysis for Peyer’s patches are presented in Table 7 and in Figure 7 to Figure 12. 
.
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Table 6 - Results of FACS analysis for mesenteric lymph nodes. Data is presented as median percentage of gated cells (25th percentile - 75th percentile) with significant difference 
compared with the control group K 
 MESENTERIC LYMPH NODES 
  Dendritic cells CD11c Macrophages F4/80 
Gr TLR2+ TLR4+ TLR2+ TLR4+  TLR2+ TLR4+ TLR2+ TLR4+ 
N 4.9 (3.8-6.1) *** 3.3 (2.0-3.8) *** 19.2 (7.4-28.2) ** 60.9 (48.5-71.4) 42.6 (36.9-50.1) 23.7 (19.5-30.0) *** 
K 18.7 (18.1-20.6) 5.0 (4.7-5.4) 3.8 (3.4-4.1) 63.5 (58.9-65.4) 42.7 (39.5-49.0) 47.5 (43.9-52.1) 
A 7.3 (6.2-8.1) *** 6.0 (4.8-7.3) 4.3 (3.3-5.8) 33.3 (28.5-37.1) *** 42.2 (33.0-52.2) 24.8 (18.8-28.3) *** 
B 16.9 (15.1-21.0) 9.3 (8.5-13.1) ** 4.4 (4.2-6.4) * 49.2 (41.1-53.6) *** 25.8 (23.0-30.0) *** 23.7 (20.3-27.0) *** 
C 78.8 (76.7-86.0) *** 33.4 (30.8-37.2) *** 33.3 (31.4-36.8) *** 61.1 (57.5-70.8) 40.3 (36.4-48.0) 34.1 (28.6-40.4) ** 
D 30.8 (28.4-31.7) ** 18.6 (16.4-19.9) ** 25.8 (23.8-27.1) ** 60.0 (57.9-64.3) 32.2 (29.6-34.5) *** 30.3 (27.6-33.0) *** 
E 26.5 (22.0-28.8) ** 25.7 (23.8-29.1) ** 17.0 (14.7-18.9) ** 59.8 (55.9-62.9) 52.5 (50.2-56.0) * 43.5 (37.6-48.6) 
  Activated gut homing T cells CCR9+ 
Gr CD4+CD69+ CD4+CD69-     CD8+CD69+ CD8+CD69- 
N 6.1 (4.7-9.5) *** 3.6 (2.8-4.3) ***   4.3 (3.0-6.4) *** 4.7 (3.2-5.4) *** 
K 2.8 (2.7-2.9) 1.1 (1.05-1.3)   1.6 (1.5-1.8) 0.5 (0.47-0.7) 
A 1.6 (1.4-1.8) *** 1.7 (1.5-1.9) **   1.2 (1.0-1.3) *** 0.99 (0.86-1.3) *** 
B 2.4 (1.7-3.6) 2.5 (2.3-2.9) ***   3.6 (2.3-4.9) ** 4.5 (3.6-5.8) *** 
C 1.7 (1.0-2.4) * 2.3 (1.4-3.0) **   0.5 (0.4-0.9) *** 0.3 (0.2-0.4) ** 
D 13.6 (11.2-17.5) *** 3.7 (3.2-4.4) ***   10.7 (7.0-12.2) *** 7.2 (6.7-7.8) *** 
E 9.7 (4.9-21.9) *** 2.9 (2.7-4.7) ***   6.8 (3.6-14.7) *** 5.5 (4.3-6.1) *** 
  Regulatory T cells CD4+CD25+ 
Gr Foxp3+CD69+ Foxp3+CD69-         
N 36.9 (30.1-43.3) *** 36.4 (25.6-58.5) *        
K 10.8 (7.6-12.5) 19.0 (17.5-26.8)     
A 21.8 (16.8-24.8) *** 47.2 (42.5-50.0) ***     
B 17.3 (14.6-20.3) *** 52.1 (47.8-60.3) ***     
C 15.1 (13.5-27.5) ** 49.0 (39.7-55.1) ***     
D 51.6 (48.5-62.4) *** 25.1 (18.5-33.4)     
E 47.4 (33.7-53.0) *** 44.6 (36.4-51.7) **         
*** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05 compared with the control group K    
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Table 7 - Results of FACS analysis for Peyer’s patches. Data is presented as median percentage of gated cells (25th percentile - 75th percentile) with significant difference compared with 
the control group K 
 PEYER'S PATCHES 
  Dendritic cells CD11c Macrophages F4/80 
Gr TLR2+ TLR4+ TLR2+ TLR4+  TLR2+ TLR4+ TLR2+ TLR4+ 
N 13.9 (12.7-17.8) *** 12.1 (10.7-15.5) *** 14.8 (12.3-17.9) ** 18.8 (16.8-21.8) *** 28.7 (26.0-31.6) *** 16.4 (14.2-17.4) *** 
K 42.5 (27.5-59.1) 35.0 (20.0-53.4) 30.2 (15.7-46.6) 60.9 (56.2-67.3) 54.7 (49.7-59.7) 62.7 (57.2-67.9) 
A 20.9 (12.3-25.5) ** 18.8 (8.6-19.6) * 26.4 (14.7-33.9) 37.3 (17.4-44.4) *** 63.5 (41.6-67.7) *** 28.8 (18.1-39.3) *** 
B 39.0 (31.5-46.6) 43.3 (36.8-54.6) 28.1 (21.6-36.9) 39.5 (37.5-49.8) *** 35.7 (33.4-44.4) *** 32.0 (39.7-39.5) *** 
C 96.2 (94.6-97.6) *** 43.4 (36.9-49.7) 44.5 (37.8-50.1) 47.5 (40.0-56.5) ** 31.6 (28.1-37.4) *** 30.0 (26.5-36.0) *** 
D 32.3 (27.5-46.6) 27.7 (23.8-42.0) ** 38.7 (33.7-58.5) 34.5 (31.6-36.7) *** 24.4 (23.5-27.4) *** 22.7 (21.7-25.7) *** 
E 25.1 (17.9-31.3) *** 27.6 (17.2-34.5) *** 18.1 (11.8-24.9) * 43.4 (32.8-55.2) ** 39.5 (35.6-42.0) *** 29.4 (20.4-37.0) *** 
  Activated gut homing T cells CCR9+ 
Gr CD4+CD69+ CD4+CD69-     CD8+CD69+ CD8+CD69- 
N 14.3 (11.0-18.3) * 3.1 (2.2-4.0) **   13.7 (10.3-17.6) * 3.0 (2.3-4.3) ** 
K 44.0 (29.5-77.5) 1.1 (0.4-1.6)   30.3 (20.8-72.1) 0.6 (0.2-0.7) 
A 23.0 (19.1-35.5) 0.8 (0.6-1.2)   15.9 (6.2-23.2) * 0.6 (0.4-0.8) 
B 24.8 (19.1-34.5) 1.2 (0.8-1.6)   43.2 (34.7-57.3) 1.7 (0.9-2.3) ** 
C 50.9 (34.6-59.8) 3.0 (1.9-4.8) *   28.4 (19.0-46.5) 0.5 (0.3-0.6) 
D 27.6 (22.5-38.5) 1.9 (1.2-2.4)   24.4 (13.2-36.9) 3.7 (3.1-4.9) *** 
E 28.1 (19.9-46.1) 2.5 (1.8-3.1) *   17.1 (7.7-25.3) * 2.2 (1.5-3.2) ** 
  Regulatory T cells CD4+CD25+ 
Gr Foxp3+CD69+ Foxp3+CD69-         
N 83.3 (71.2-92.7) 8.8 (2.5-13.2)        
K 73.8 (72.0-79.4) 0.6 (0.2-5.5)     
A 86.2 (79.7-88.9) * 0.0 (0.0-0.8) *     
B 81.3 (69.2-88.2) 3.1 (0.3-5.6)     
C 84.9 (81.6-89.5) ** 0.2 (0.0-1.5)     
D 85.4 (73.0-90.6) 2.5 (0.0-10.5)     
E 91.2 (81.8-96.2) ** 5.0 (2.2-9.9)         
*** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05 compared with the control group K    
 18 
 
Gram-positive bacteria induced activation of gated dendritic cells (DC) from Peyer’s patches 
(Figure 7) was significantly lower (p<0.001) in the untreated group N (13.9 (12.7–17.8)) 
compared to the control group K (42.5 (35.9–59.1)). Furthermore, activation was 
significantly lower in the antagonist groups A (19.4 (9.8–24.7), p=0.001) and E (24.4 (17.9–
31.3), p=0.008), but significantly higher in the group C (96.2 (94.6–97.6), p<0.001). 
 
Figure 7 – Statistical differences of percentage gated Gram-positive bacteria activated dendritic cells collected from 
Peyer’s patches 
Gram-negative bacteria induced activation of gated DCs from Peyer’s patches (Figure 8) was 
significantly lower (p=0.010) in the untreated group N (12.1 (10.7–15.5)) compared to the 
control group K (35.0 (20.0–53.4)). Additionally, the value was significantly lower (p=0.020) 
in the antagonist group A (16.7 (7.9–19.4)). Differences between the group K and the other 
antagonist groups were not statistically significant. No significant differences between the 
groups were found in double positive (TLR2+ TLR4+) dendritic cells (p=0.064).  
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Figure 8 - Statistical differences of percentage gated Gram-negative bacteria activated dendritic cells collected from 
Peyer’s patches 
Gram-positive bacteria induced activation of macrophages from Peyer’s patches (Figure 9) 
was significantly lower (p<0.001) in the untreated group N (18.8 (16.8–21.8)) compared with 
the group K (63.4 (56.2–67.3)). The percentage of activated cells was significantly lower in 
every antagonistic group, and the lowest in the antagonist group A (13.1 (6.5–21.6), p<0.001). 
 
Figure 9 - Statistical differences of percentage gated Gram-positive bacteria activated macrophages collected from 
Peyer’s patches 
Gram-negative bacteria induced activation of macrophages from Peyer’s patches (Figure 10) 
was significantly lower (p<0.001) in the untreated group N (28.7 (26.0–31.6)) compared with 
the group K (55.1 (51.7–60.6)). The percentage of activated cells was significantly lower in 
every antagonistic group. 
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Figure 10 - Statistical differences of percentage gated Gram-negative bacteria activated macrophages collected 
from Peyer’s patches 
Unlike with DCs, there were significant differences in gated TLR2+ TLR4+ double activated 
macrophages (Figure 11). Activation percentage was significantly lower in the group N (16.4 
(14.2–17.4)) compared to the group K (62.7 (57.2–67.9)) with p<0.001. The double 
activation percentage was significantly lower in every antagonist group and among them the 
lowest in the group D (22.7 (21.7-25.7)). 
 
Figure 11 - Statistical differences of percentage gated both Gram-negative and Gram-positive bacteria activated 
macrophages collected from Peyer’s patches 
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The percentage of the CD4+ helper T cells expressing the gut homing chemokine receptor 
(CCR9), and CD69 (Figure 12) was significantly lower in the group N (14.3 (11.0–18.3)) than 
in the group K (44.0 (29.5–77.5)), p=0.011. No significant differences were found between 
the groups K and A–E. However, the group A is close to have significantly lower percentage 
(23.0 (19.1–35.5)) compared to the group K (p=0.056). 
 
Figure 12 - Statistical differences of percentage gated CD4+ helper T cells expressing the gut homing chemokine 
receptor (CCR9), and CD69 collected from Peyer’s patches 
The percentage of the CD8+ cytotoxic T cells expressing CCR9 and CD69 (Figure 13) was 
significantly lower in the group N (13.7 (10.3–17.6)) than in the group K (30.3 (20.8–72.1)), 
p=0.018. Significantly lower percentages were also in the groups A (15.9 (6.2–23.2), p=0.037) 
and E (17.1 (7.7–25.3), p=0.029). 
 
Figure 13 - Statistical differences of percentage gated CD8+ cytotoxic T cells expressing the gut homing chemokine 
receptor (CCR9), and CD69 collected from Peyer’s patches 
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5 Discussion 
In the present study, the effects and safety of selected antagonistic bacteria has been 
evaluated by their competence to prevent Escherichia coli contamination through plant leaves, 
survivability with pelleting substance, and the immune response in mice. A few isolates from 
bagged rocket salad were identified to get a general idea of the dominating, culturable 
microflora through the shelf-life period. 
5.1 Microflora and quality of bagged rocket salad 
The sequencing results (Table 3) show that Pseudomonas and Aeromonas genera are the most 
abundant among these samples. Pseudomonas are Gram-negative bacteria, commonly found 
from leafy green vegetables. In a Norwegian study, 51 samples of Diplotaxis tenuifolia and 
Latuca sativa were identified by Sanger sequencing and the 30% of isolates were found to be 
Pseudomonas spp. (Dees, Lysøe, Nordskog, and Brurberg, 2014). Aeromonas spp. are Gram-
negative rods that are omnipresent in soil, water and vegetation (McMahon and Wilson, 
2001), and have been isolated from extensive range of fresh produce, including leafy green 
vegetables (Merino, Rubires, Knøchel, and Tomás, 1995). However, three of Aeromonas 
isolates were identified to be Aeromonas hydrophilia, which is the most well-known from the 
total of six species of Aeromonas that are human pathogens (Elhariry, 2011). A. hydrophilia has 
found to be able to form a biofilm on the leaves of cabbage and lettuce in vitro (Elhariry, 
2011), which should be taken into consideration when washing the leafy greens before 
consuming. Lysinibacillus is relatively common genus in soil (Ahmed, Yokota, Yamazoe, and 
Fujiwara, 2007), so it is not surprising to find it from rocket salad. In addition, Lysinibacillus 
fusiformis has been previously isolated from cacao leaf (Melnick, Suárez, Bailey, and Backman, 
2011), so it seems to have an ability to attach on plant tissue. 
More surprising findings were Rheinheimera, Chryseobacterium, and Shewanella. There was no 
publications about Rheinheimera in vegetables, fruits or berries, but some studies present that 
Rheinheimera sp. have been isolated from soil in South Korea (Ryu, Chung, Park, Lee, Lee and 
Jeon, 2008), and from irrigation water, including Rheinheimera soli B29 (Hao, 2012). 
Chryseobacterium indoltheticum is isolated from marine mud (Wu, Wu, and Liu, 2012) but no 
extensive publications could be found. Shewanella has been previously found from 
hydroponic lettuce growing systems (Rivera, Vélez, Zayas, and Llamas, 2015), even though 
Shewanella putrefaciens is connected to the smell of spoiled fish (Gram and Huss, 1996). It has 
also known to create biofilms on food processing surfaces (Bagge, Hjelm, Johansen, Huber, 
and Gram, 2001). Based on the publications, the most thinkable source for these genera 
would be contaminated processing surfaces or irrigation water from marine source. However, 
it needs to be kept in mind that these results are only putative identifications based on 16S 
rRNA gene sequencing, so errors between species and especially strains are plausible. 
5.2 Effects and survivability of selected antagonists 
Unlike previous studies, the present study showed no significant differences in E. coli 
concentrations in plants treated with antagonists compared with negative control (Table 4). 
Possible reasons were thought to be a contamination of the rockwool plugs during dipping, 
too high dose of E. coli during dipping, or a high death rate of antagonistic bacteria during 
seed inoculation. Rockwool plug contamination may have contaminated the nutrient solution, 
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which would have led sprouts getting contaminated also through roots, not only the leaves.  
The possibility of antagonists not surviving in a solution with pelleted seeds was taken into 
consideration mostly because the experiments in the earlier studies were done with non-
pelleted seeds. Seed pelleting is a common treatment in the agriculture, and reasons for it are 
for example to protect seeds from soil fungi such as Rhizoctonia solani or Pythium spp., and to 
have uniform size and shape for the easier planting (Taylor and Harman, 1990). Therefore it 
could be possible that the coating material contains antimicrobial substances that effect on 
the survivability of antagonists. This was tested with a small experiment, which showed that 
the amount of total bacterial count in antagonists E and D reduced 1–2 log10 CFU/gram. 
Unfortunately this does not explain the bad results with all antagonists. However, even if the 
pellet does not cause antagonist to die in high rates, the pellet may work as a barrier to water 
diffusion (Taylor and Harman, 1990). Pelleting materials are used to modify the seeds to 
adapt certain moisture levels, which may have an effect on pore size and particle size of used 
materials (Taylor and Harman, 1990) and therefore hinder the antagonist from reaching the 
seed and inoculating the plant. 
5.3 Animal experiment 
The animal experiment data shows that the mice used in the experiment consumed the typical 
amount of water per individual per day (Bachmanov, Reed, Beauchamp, and Tordoff, 2002). 
The daily feed intake per individual was approximately 2.2 grams of feed, which is a little 
lower than what is mentioned in Bachmanov et al. study, but the study also states that the 
feed intake is related to the body weight of mice (Bachmanov et al., 2002). Since every group 
had a similar consumption level of feed and water, and no significant differences in the body 
weight development were found, it is relatively safe to say that antagonist treatment had no 
effect on the typical consumption behaviour of mice. The notable difference and peak in 
water intake between normal group N and K, A–E (Figure 6) is due to off-taste of antibiotics, 
and for example clindamycin is known to have a bitter or metallic taste (de Groot and van 
Puijenbroek, 2007).  
Even though it is relatively difficult to draw exact conclusions from FACS data alone, a few 
notes can be made. If observing the results from Peyer’s patches, it can be seen that the 
expression of both TLR2 and TLR4 (including double activation on macrophages) in 
dendritic cells and macrophages is significantly higher in E. coli treated control group K. This 
result goes in line with a study, in which the similar expression pattern was found from 
children with inflammatory bowel disease (IBS) (Szebeni, Veres, Dezsõfi, Rusai, Vannay, 
Mraz, Majorova, and Arató, 2007). This indicates that mice were probably having E. coli 
induced inflammation, and therefore the pre-treatment was successful. However, if 
observing results for antagonist A it can be seen that the activation of TLR2 and TLR4 in 
expressing cells is remarkably lower compared with K. The percentage seems to be on similar 
level as in untreated group N. This may suggest that the antagonist A is able to suppress the 
immune response. The possible suppression is also visible in activated CCR9+CD4+CD69+ 
and CCR9+CD8+CD69+ cells (Figure 12 and Figure 13) in Peyer’s patches. Similar trend 
applies for the most of tested antagonists. The only antagonist that blatantly breaks the 
pattern is the antagonist C. As it can be seen in Figure 7, the CD11c+TLR2+ DC activation 
in the group C is remarkably high (96.2 (94.6–97.6)) compared to any other group. 
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Antagonist C is a Gram-positive bacteria, so the high activation percentage may indicate that 
the antagonist is able to colonise in the gut of mice. Since the mechanism of the antagonist 
C in the gut is not completely known, colonisation may not be wanted. However, it seems 
that F4/80+TLR2+ macrophage activation is a lot lower (47.5 (40.0–56.5)) compared with 
DCs. Therefore there is a chance that a possible colonisation does not trigger an eliminative 
immune response. The results from CC9+CD69+ expressing cytotoxic CD8+ T cells from 
Peyer’s patches (Figure 13) are supporting this theory. Similar patterns with the antagonists 
A and C in Peyer’s patches can be seen in mesenteric lymph nodes (Table 6), though the 
differences are not as notable and sometimes not significant compared with control group 
K. To fully understand the possible resemblances, a deeper analysis of several possible 
activation and support mechanisms in tissues should be taken into consideration and studied 
more. Based on the FACS analysis it is relatively safe to say that the large spleen on the 
mouse C1.4 was not caused by the antagonist, but natural variety. 
6 Conclusions and future 
As we live in a hectic world, ready-to-eat salads are a convenient way to increase the 
consumption of vegetables. However, as the results of this study and several other 
publications show, leafy green vegetables contain a great amount of different bacteria with 
potential human pathogens. Some of these bacteria are naturally occurring in soil or water, 
while others come from contaminated sources. Obviously this does not mean that the RTE 
salad production has to be stopped, but producers shall keep in mind the importance of 
process hygiene especially since the process does not have critical control points to eliminate 
possible microbial hazards. In addition, several of the present bacteria are capable to create 
biofilms on surfaces including process equipment and leafy green vegetables. Biofilms are 
often difficult to remove from equipment surfaces, which increases the contamination risk. 
Unfortunately, the potential of the antagonists on hydroponically grown spinach sprouts was 
not clear from the results. However, this is very likely caused by technical difficulties. In the 
study, physical and chemical properties of pelleting materials were not taken into 
consideration. Therefore, it could be helpful to see how the positive results can be obtained 
with pelleted seeds. This will most likely require some changes in inoculation method or time. 
Even if it may be time consuming to look for an optimal method, it will help with future 
field studies. Based on the animal experiment, the tested antagonists were not causing 
changes in water and feed consumption of mice. This would indicate that mice do not feel 
sick when treated with the antagonists. Cursory observation of FACS results didn’t show 
alarming immune reactions, but more profound analysis is necessary before conclusions can 
be made. In addition, the analysis of biopsies, liver, and faecal content are required to get a 
better understanding of the overall situation. Despite of poor results in the antagonistic effect 
experiment, preliminary results indicate that selected antagonists do not trigger negative 
immune response, and therefore the development of safer salad shall be continued. 
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Appendix 1 
Chemicals used in the preparation of nutrient stock solutions. 
 
  
Chemicals Chemical formula 
Amount in 
 grams (g/l) 
B 
Ethylenediaminetetraacetic acid ferric sodium salt FeEDTA 0.444 
Magnesium Sulphate Heptahydrate MgSO4 · 7H2O 0.00845 
Ammonium Dihydrogen Phosphate (NH4)H2PO4 1.15 
Potassium Dihydrogen Phosphate KH2PO4 1.3609 
Ammonium Nitrate NH4NO3 1.92 
C 
Zinc Sulphate Hepta Hydrate ZnSO4 · 7H2O 0.0115 
Sodium Tetraborate Deca Hydrate Na2B4O7 · 10H2O 0.11442 
Ammonium heptamolybdate tetrahydrate (NH4)6Mo7O24 0.00618 
Copper sulphate Pentahydrate CuSO4 · 5H2O 0.0019 
Manganese sulphate Monohydrate MnSO4 · H2O 0.00845 
D 
Calcium Hydroxide Ca(OH)2 0.7 
Ammonium Sulphate (NH4)2SO4 0.132 
Potassium Sulphate K2SO4 4.357 
 
 
  
Appendix 2 
Chemicals used in Hogness freezing media. 
Chemicals Amount per 200 ml 
K2HPO4 0.17 g 
KH2PO4 0.04 g 
Tri-natrium-citrat-dihydrat 0.3 g 
MgSO4 · 7H2O 0.05 g 
Glycerol 99.5% 24.3 ml 
H2O 175 ml 
 
  
Appendix 3 
Detailed schedule for animal experiment from May 25 to June 20, 2017 
Date Groups N1 & N2 Groups K1 & K2 Groups A1 & A2 Groups B1 & B2 Groups C1 & C2 Groups D1 & D2 Groups E1 & E2 
25-May Fructose       
26-May Fructose Antibiotics      
27-May Fructose Antibiotics Antibiotics     
28-May Freezing media Antibiotics Antibiotics Antibiotics    
29-May Freezing media E.coli Antibiotics Antibiotics Antibiotics   
30-May Freezing media E.coli E.coli Antibiotics Antibiotics Antibiotics  
31-May Freezing media Freezing media E.coli E.coli Antibiotics Antibiotics Antibiotics 
01-Jun Freezing media Freezing media Antagonist A E.coli E.coli Antibiotics Antibiotics 
02-Jun Freezing media Freezing media Antagonist A Antagonist B E.coli E.coli Antibiotics 
03-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C E.coli E.coli 
04-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D E.coli 
05-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
06-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
07-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
08-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
09-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
10-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
11-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
12-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
13-Jun Freezing media Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
14-Jun Operation Freezing media Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
15-Jun  Operation Antagonist A Antagonist B Antagonist C Antagonist D Antagonist E 
16-Jun   Operation Antagonist B Antagonist C Antagonist D Antagonist E 
17-Jun    Operation Antagonist C Antagonist D Antagonist E 
18-Jun     Operation Antagonist D Antagonist E 
19-Jun      Operation Antagonist E 
20-Jun       Operation 
  
Appendix 4 
 FACS sample preparation protocol used in this experiment. 
1 
Transfer tissues (Peyer’s patches and mesenteric lymph nodes) to 1.5 ml tubes 
with 1 ml HBSS. 
Cut Peyer’s patches with curved scissor into 1 mm pieces. 
Remove fat from mesenteric lymph nodes and cut into 1mm pieces. 
2 Centrifuge 100 g, 2 min at 4 °C. 
3 
Create digestion mix. Mix enzymes (collagense P, dispase II and DNase I from 
bovine pancreas, see the end of this Appendix) with HBSS gently. Avoid foaming! 
4 
 
Remove supernatant and excess fat 
5 Add 500 µl digestion mix with cut pipette tip. Transfer cells to FACS tube. 
6 Wash old tube w. 500 µl digestion mix and add to FACS tube 
7 
Shake gently with rocker at 37 °C for 10 min. Have digestion mix in the same rack 
as well too. 
8 Put 50 ml FBSS/10% FBS and 5 ml FBS/sample in falcon tube and place on ice 
9 
Take out sample tube and pipet up and down (cut tip if needed) 20 times. Let 
sample settle. 
10 Transfer supernatant to FBS tube 
11 Add 1 ml digestion buffer to remaining tissue. Incubate at 37 °C for 10 min. 
12 Repeat steps 7 - 11 for 1 - 2 times 
13 Centrifuge FBS tube at 1400 rpm (250g) at 4 °C for 5 min 
14 Remove supernatant 
15 Resuspend cells in 2 ml of FBSS/10% FBS 
16 Put suspension through 40 µM filter 
17 Add 1 ml HBSS/FBS to filter. Transfer flow through to FACS tube. 
18 Centrifuge for 5 min at 4 °C, 1400 rpm 
19 Remove supernatant 
20 Resuspend in cells in 500 µl of HBSS 
21 
Stain with Türk’s solution – 2 µl per 18 µl of cell suspension (Peyer’s patches), 1 µl 
per 19 µl of cell suspension (lymph nodes). 
22 Load Bürker chamber, count 2 A chambers, take average 
23 Calculate required volume for 106 dilution of cells 
24 Save excess cells to unstained tube 
25 Make antibody mix (see the end of this Appendix), add to cell tubes 
26 Make compensation tubes with 0,5 µl antibody per tube 
27 Incubate for 15 min at 4 °C 
28 Wash stained cells with 800 µl FACS buffer, centrifuge at 1200 rpm for 5 min 
29 Discard supernatant and resuspend cells in 400 µl FACS buffer 
30 Dilute Fix/Permeability concentration 1:3 in Fix/Permeability diluent 
31 Add 600 µl per sample. Vortex gently. 
32 Incubate at 4 °C for 1 h 
33 Dilute permeability buffer 
  
34 Add 600 µl per sample. Centrifuge 1200 rpm for 5 min. Discard supernatant. 
35 
Repeat step 37, add permeability buffer: 83 µl for lymph nodes and 167 µl for 
Peyer’s patches 
36 Add Foxp3 and dump channel 
37 Incubate for 45 min at 4 °C 
38 wash w 800 µl perm buffer 
39 Centrifuge for 5 min, 1200 rpm 
40 Discard supernatant, resuspend cells in 400 µl FACS buffer 
41 Run on FACS 
 
 
 Antibody master mix for 22 
samples 
Panel1 V (µl) 
CD16/32 11.0 
TLR2 5.5 
CD11c 2.75 
F4/80 5.5 
TLR4 5.5 
Vol per sample tube 1.375 
  
Panel 2  
CD16/CD32 11.0 
CCR9-FITC 2.75 
CD4-PE 1.375 
CD69-PerCP Cy5.5 5.5 
CD8a-APC 1.375 
Vol per sample tube 1.0 
  
Panel 3a  
CD16/CD32 11.0 
CD4-PE 1.375 
CD69-PerCP Cy5.5 5.5 
CD25-APC 1.375 
Vol per sample tube 0.875 
  
Panel 3b  
Foxp3-FITC 11.0 
CD16/CD32 11.0 
Vol per sample tube 1.0 
Digestion mix 
Stock Vol/sample (ml) 
Collagenase P 0.08 
Dispase II 0.32 
Dnase I 0.1 
HBSS 4.25 
 
Dilute Fixation buffer for 22 samples 
Stock Vol (ml) 
Fix/Perm concentrate 3.3 
Fix/Perm diluent 9.9 
Perm buffer 4.4 
dH2O 39.6 
 
  
Appendix 5 
Feed weights (g) at the beginning, added feed, remaining feed on the operation day, and the median consumption. 
Group N1 N2 K1 K2 A1 A2 B1 B2 C1 C2 D1 D2 E1 E2 
Feed (g)               
Start 282.1 345.9 357.2 244.5 237.3 248.3 268.8 248.7 208.8 184.7 251.5 299.8 209.0 182.0 
Added 160.7 95.5 97.8 142.8 149.9 128.0 117.1 254.2 256.1 190.2 272.6 131.0 200.6 235.7 
End 130.9 126.6 143.6 64.0 63.2 90.4 67.0 195.2 146.7 61.4 198.9 127.6 97.5 90.9 
Consumed 311.9 314.8 311.4 323.3 324.0 285.9 318.9 307.7 318.2 313.5 325.2 303.2 312.1 326.8 
Per animal 62.4 63.0 62.3 64.7 64.8 57.2 63.8 61.5 63.6 62.7 65.0 60.6 62.4 65.4 
Per animal 
per day 
2.2 2.2 2.2 2.3 2.3 2.0 2.3 2.2 2.3 2.2 2.3 2.2 2.2 2.3 
 
  
Appendix 6 
Animal weight (g) chart with different time point comparisons 
 S A E 
Δm 
total   Δm total/feed intake (¤) 
 
Animal 
ID Start After E.coli End E-S A-S E-A (E-S)* (A-S)* (E-A)*  
N1.1 19.9 20.1 21.4 1.5 0.2 1.3 0.02 0.00 0.02 62.38 
N1.2 20.0 20.2 22.6 2.6 0.2 2.4 0.04 0.00 0.04 62.38 
N1.3 18.9 19.1 20.8 1.9 0.2 1.7 0.03 0.00 0.03 62.38 
N1.4 19.2 19.1 21.9 2.7 -0.1 2.8 0.04 0.00 0.04 62.38 
N1.5 20.0 20.4 20.9 0.9 0.4 0.5 0.01 0.01 0.01 62.38 
N2.1 19.7 19.1 21.8 2.1 -0.6 2.7 0.03 -0.01 0.04 62.98 
N2.2 19.9 20.2 21.5 1.6 0.3 1.3 0.03 0.00 0.02 62.98 
N2.3 21.3 20.8 21.6 0.3 -0.5 0.8 0.00 -0.01 0.01 62.98 
N2.4 21.2 20.0 20.9 -0.3 -1.2 0.9 0.00 -0.02 0.01 62.98 
N2.5 19.6 19.8 20.7 1.1 0.2 0.9 0.02 0.00 0.01 62.98 
K1.1 22.0 22.8 23.8 1.8 0.8 1.0 0.03 0.01 0.02 62.28 
K1.2 20.7 21.4 22.0 1.3 0.7 0.6 0.02 0.01 0.01 62.28 
K1.3 20.4 22.0 22.2 1.8 1.6 0.2 0.03 0.03 0.00 62.28 
K1.4 20.3 21.3 21.7 1.4 1.0 0.4 0.02 0.02 0.01 62.28 
K1.5 20.1 20.0 21.7 1.6 -0.1 1.7 0.03 0.00 0.03 62.28 
K2.1 18.7 19.1 20.0 1.3 0.4 0.9 0.02 0.01 0.01 64.66 
K2.2 19.8 19.5 20.3 0.5 -0.3 0.8 0.01 0.00 0.01 64.66 
K2.3 21.0 21.5 22.7 1.7 0.5 1.2 0.03 0.01 0.02 64.66 
K2.4 21.1 21.7 23.4 2.3 0.6 1.7 0.04 0.01 0.03 64.66 
K2.5 20.7 21.1 20.9 0.2 0.4 -0.2 0.00 0.01 0.00 64.66 
A1.1 20.6 21.9 21.5 0.9 1.3 -0.4 0.01 0.02 -0.01 64.8 
A1.2 20.8 20.7 20.3 -0.5 -0.1 -0.4 -0.01 0.00 -0.01 64.8 
A1.3 20.4 21.0 22.4 2.0 0.6 1.4 0.03 0.01 0.02 64.8 
A1.4 20.6 20.9 21.0 0.4 0.3 0.1 0.01 0.00 0.00 64.8 
A1.5 20.2 21.7 21.8 1.6 1.5 0.1 0.02 0.02 0.00 64.8 
A2.1 20.5 20.6 21.4 0.9 0.1 0.8 0.02 0.00 0.01 57.18 
A2.2 21.5 22.6 23.5 2.0 1.1 0.9 0.03 0.02 0.02 57.18 
A2.3 20.3 20.6 22.1 1.8 0.3 1.5 0.03 0.01 0.03 57.18 
A2.4 21.0 20.5 19.4 -1.6 -0.5 -1.1 -0.03 -0.01 -0.02 57.18 
A2.5 20.3 21.0 21.3 1.0 0.7 0.3 0.02 0.01 0.01 57.18 
B1.1 19.5 20.5 21.4 1.9 1.0 0.9 0.03 0.02 0.01 63.78 
B1.2 19.4 19.6 20.0 0.6 0.2 0.4 0.01 0.00 0.01 63.78 
B1.3 20.6 22.7 22.7 2.1 2.1 0.0 0.03 0.03 0.00 63.78 
B1.4 20.5 21.9 21.4 0.9 1.4 -0.5 0.01 0.02 -0.01 63.78 
B1.5 20.4 21.1 21.8 1.4 0.7 0.7 0.02 0.01 0.01 63.78 
B2.1 19.9 20.9 21.8 1.9 1.0 0.9 0.03 0.02 0.01 61.54 
B2.2 20.5 21.3 22.7 2.2 0.8 1.4 0.04 0.01 0.02 61.54 
(¤) Feed 
intake / 5 (# 
animal per 
cage) 
  
B2.3 19.5 21.2 21.6 2.1 1.7 0.4 0.03 0.03 0.01 61.54 
B2.4 21.6 22.5 22.4 0.8 0.9 -0.1 0.01 0.01 0.00 61.54 
B2.5 19.6 21.3 21.8 2.2 1.7 0.5 0.04 0.03 0.01 61.54 
C1.1 20.7 22.7 22.7 2.0 2.0 0.0 0.03 0.03 0.00 63.64 
C1.2 19.9 21.5 21.9 2.0 1.6 0.4 0.03 0.03 0.01 63.64 
C1.3 20.6 22.0 22.1 1.5 1.4 0.1 0.02 0.02 0.00 63.64 
C1.4 20.5 21.1 21.9 1.4 0.6 0.8 0.02 0.01 0.01 63.64 
C1.5 19.1 20.7 19.9 0.8 1.6 -0.8 0.01 0.03 -0.01 63.64 
C2.1 20.2 18.5 23.0 2.8 -1.7 4.5 0.04 -0.03 0.07 62.7 
C2.2 20.3 18.6 20.5 0.2 -1.7 1.9 0.00 -0.03 0.03 62.7 
C2.3 21.1 19.0 21.2 0.1 -2.1 2.2 0.00 -0.03 0.04 62.7 
C2.4 19.6 18.2 20.6 1.0 -1.4 2.4 0.02 -0.02 0.04 62.7 
C2.5 20.5 19.9 21.7 1.2 -0.6 1.8 0.02 -0.01 0.03 62.7 
D1.1 20.0 21.5 22.7 2.7 1.5 1.2 0.04 0.02 0.02 65.04 
D1.2 19.8 21.8 22.4 2.6 2.0 0.6 0.04 0.03 0.01 65.04 
D1.3 20.1 22.2 22.5 2.4 2.1 0.3 0.04 0.03 0.00 65.04 
D1.4 19.4 21.2 22.5 3.1 1.8 1.3 0.05 0.03 0.02 65.04 
D1.5 20.5 21.0 22.1 1.6 0.5 1.1 0.02 0.01 0.02 65.04 
D2.1 19.6 21.7 21.5 1.9 2.1 -0.2 0.03 0.03 0.00 60.64 
D2.2 20.0 21.3 20.6 0.6 1.3 -0.7 0.01 0.02 -0.01 60.64 
D2.3 19.4 21.0 21.0 1.6 1.6 0.0 0.03 0.03 0.00 60.64 
D2.4 19.1 20.3 18.4 -0.7 1.2 -1.9 -0.01 0.02 -0.03 60.64 
D2.5 20.0 21.4 20.8 0.8 1.4 -0.6 0.01 0.02 -0.01 60.64 
E1.1 20.9 22.3 22.1 1.2 1.4 -0.2 0.02 0.02 0.00 62.42 
E1.2 19.2 20.5 21.1 1.9 1.3 0.6 0.03 0.02 0.01 62.42 
E1.3 19.6 20.7 21.8 2.2 1.1 1.1 0.04 0.02 0.02 62.42 
E1.4 18.6 19.2 19.3 0.7 0.6 0.1 0.01 0.01 0.00 62.42 
E1.5 19.9 21.2 21.8 1.9 1.3 0.6 0.03 0.02 0.01 62.42 
E2.1 20.1 21.3 21.1 1.0 1.2 -0.2 0.02 0.02 0.00 65.36 
E2.2 20.0 21.8 23.2 3.2 1.8 1.4 0.05 0.03 0.02 65.36 
E2.3 20.2 20.1 20.7 0.5 -0.1 0.6 0.01 0.00 0.01 65.36 
E2.4 19.3 21.0 22.9 3.6 1.7 1.9 0.06 0.03 0.03 65.36 
E2.5 20.5 21.9 23.7 3.2 1.4 1.8 0.05 0.02 0.03 65.36 
  
Appendix 7 
Spleen weights and compensations with feed intakes. (E-S)*, (A-S)* and (E-A)* are the 
same values as in Appendix  
Animal ID m (spleen) 
Spleen/(end 
weight/feed 
intake) Spleen/(E-S)* Spleen/(A-S)* Spleen/(E-A)* 
N1.1 0.097 0.283 4.03 30.25 4.65 
N1.2 0.090 0.248 2.16 28.07 2.34 
N1.3 0.088 0.264 2.89 27.45 3.23 
N1.4 0.112 0.319 2.59 -69.87 2.50 
N1.5 0.089 0.266 6.17 13.88 11.10 
N2.1 0.094 0.272 2.82 -9.87 2.19 
N2.2 0.096 0.281 3.78 20.15 4.65 
N2.3 0.126 0.367 26.45 -15.87 9.92 
N2.4 0.082 0.247 -17.21 -4.30 5.74 
N2.5 0.107 0.326 6.13 33.69 7.49 
K1.1 0.080 0.209 2.77 6.23 4.98 
K1.2 0.092 0.260 4.41 8.19 9.55 
K1.3 0.091 0.255 3.15 3.54 28.34 
K1.4 0.090 0.258 4.00 5.61 14.01 
K1.5 0.100 0.287 3.89 -62.28 3.66 
K2.1 0.079 0.255 3.93 12.77 5.68 
K2.2 0.078 0.248 10.09 -16.81 6.30 
K2.3 0.099 0.282 3.77 12.80 5.33 
K2.4 0.095 0.263 2.67 10.24 3.61 
K2.5 0.086 0.266 27.80 13.90 -27.80 
A1.1 0.071 0.214 5.11 3.54 -11.50 
A1.2 0.061 0.195 -7.91 -39.53 -9.88 
A1.3 0.100 0.289 3.24 10.80 4.63 
A1.4 0.074 0.228 11.99 15.98 47.95 
A1.5 0.093 0.276 3.77 4.02 60.26 
A2.1 0.091 0.243 5.78 52.03 6.50 
A2.2 0.097 0.236 2.77 5.04 6.16 
A2.3 0.090 0.233 2.86 17.15 3.43 
A2.4 0.087 0.256 -3.11 -9.95 -4.52 
A2.5 0.090 0.242 5.15 7.35 17.15 
B1.1 0.074 0.221 2.48 4.72 5.24 
B1.2 0.079 0.252 8.40 25.19 12.60 
B1.3 0.082 0.230 2.49 2.49 0 
B1.4 0.097 0.289 6.87 4.42 -12.37 
B1.5 0.094 0.275 4.28 8.56 8.56 
B2.1 0.104 0.294 3.37 6.40 7.11 
  
B2.2 0.095 0.258 2.66 7.31 4.18 
B2.3 0.084 0.239 2.46 3.04 12.92 
B2.4 0.105 0.288 8.08 7.18 -64.62 
B2.5 0.113 0.319 3.16 4.09 13.91 
C1.1 0.086 0.241 2.74 2.74 0 
C1.2 0.071 0.206 2.26 2.82 11.30 
C1.3 0.118 0.340 5.01 5.36 75.10 
C1.4 0.227 0.660 10.32 24.08 18.06 
C1.5 0.096 0.307 7.64 3.82 -7.64 
C2.1 0.097 0.264 2.17 -3.58 1.35 
C2.2 0.088 0.269 27.59 -3.25 2.90 
C2.3 0.091 0.269 57.06 -2.72 2.59 
C2.4 0.074 0.225 4.64 -3.31 1.93 
C2.5 0.115 0.332 6.01 -12.02 4.01 
D1.1 0.085 0.244 2.05 3.69 4.61 
D1.2 0.087 0.253 2.18 2.83 9.43 
D1.3 0.120 0.347 3.25 3.72 26.02 
D1.4 0.090 0.260 1.89 3.25 4.50 
D1.5 0.109 0.321 4.43 14.18 6.44 
D2.1 0.098 0.276 3.13 2.83 -29.71 
D2.2 0.094 0.277 9.50 4.38 -8.14 
D2.3 0.096 0.277 3.64 3.64 0 
D2.4 0.081 0.267 -7.02 4.09 -2.59 
D2.5 0.101 0.294 7.66 4.37 -10.21 
E1.1 0.091 0.257 4.73 4.06 -28.40 
E1.2 0.074 0.219 2.43 3.55 7.70 
E1.3 0.096 0.275 2.72 5.45 5.45 
E1.4 0.075 0.243 6.69 7.80 46.81 
E1.5 0.093 0.266 3.06 4.47 9.68 
E2.1 0.091 0.282 5.95 4.96 -29.74 
E2.2 0.101 0.285 2.06 3.67 4.72 
E2.3 0.081 0.256 10.59 -52.94 8.82 
E2.4 0.097 0.277 1.76 3.73 3.34 
E2.5 0.112 0.309 2.29 5.23 4.07 
 
